Hillard CJ et al. |
Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide. |
1995 |
J. Neurochem. |
pmid:7830060
|
Witting A et al. |
Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice. |
2004 |
J. Neurochem. |
pmid:15189359
|
Subbanna S et al. |
Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol lipase does not cause neurodegeneration in neonatal mice. |
2015 |
J. Neurochem. |
pmid:25857698
|
Wu X et al. |
Alteration of endocannabinoid system in human gliomas. |
2012 |
J. Neurochem. |
pmid:22176552
|
Maccarrone M et al. |
Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex. |
2004 |
J. Neurochem. |
pmid:15147522
|
Butt C et al. |
Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. |
2008 |
J. Neurochem. |
pmid:18194436
|
Basavarajappa BS and Hungund BL |
Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells. |
1999 |
J. Neurochem. |
pmid:9930723
|
De Lago E et al. |
Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations. |
2006 |
J. Neurochem. |
pmid:16899063
|
Nogueron MI et al. |
Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons. |
2001 |
J. Neurochem. |
pmid:11677265
|
Vogel Z et al. |
Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. |
1993 |
J. Neurochem. |
pmid:8515284
|
Jarrahian A et al. |
Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. |
2000 |
J. Neurochem. |
pmid:10820223
|
Hansen HH et al. |
Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. |
2001 |
J. Neurochem. |
pmid:11579150
|
Di Marzo V et al. |
Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats. |
2000 |
J. Neurochem. |
pmid:10737621
|
Mestre L et al. |
Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis. |
2005 |
J. Neurochem. |
pmid:15748152
|
Oz M et al. |
The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism. |
2010 |
J. Neurochem. |
pmid:20050977
|
Di Marzo V et al. |
Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. |
2000 |
J. Neurochem. |
pmid:11080195
|
Rubino T et al. |
Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats. |
2000 |
J. Neurochem. |
pmid:11080200
|
Wiles AL et al. |
N-Arachidonyl-glycine inhibits the glycine transporter, GLYT2a. |
2006 |
J. Neurochem. |
pmid:16899062
|
Berger C et al. |
Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? |
2004 |
J. Neurochem. |
pmid:15009671
|
Hill MN et al. |
Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. |
2008 |
J. Neurochem. |
pmid:18643796
|
Placzek EA et al. |
Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol. |
2008 |
J. Neurochem. |
pmid:18778304
|
Bisogno T |
Endogenous cannabinoids: structure and metabolism. |
2008 |
J. Neuroendocrinol. |
pmid:18426492
|
Capasso R and Izzo AA |
Gastrointestinal regulation of food intake: general aspects and focus on anandamide and oleoylethanolamide. |
2008 |
J. Neuroendocrinol. |
pmid:18426498
|
Stefano GB |
Autoimmunovascular regulation: morphine and anandamide and ancondamide stimulated nitric oxide release. |
1998 |
J. Neuroimmunol. |
pmid:9610675
|
Eisenstein TK et al. |
Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors. |
2007 |
J. Neuroimmunol. |
pmid:17640739
|
Schwarz H et al. |
Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. |
1994 |
J. Neuroimmunol. |
pmid:7962480
|
De Laurentiis A et al. |
The hypothalamic endocannabinoid system participates in the secretion of oxytocin and tumor necrosis factor-alpha induced by lipopolysaccharide. |
2010 |
J. Neuroimmunol. |
pmid:20207018
|
Hollis JH et al. |
The endocannabinoid arachidonylethanolamide attenuates aspects of lipopolysaccharide-induced changes in energy intake, energy expenditure and hypothalamic Fos expression. |
2011 |
J. Neuroimmunol. |
pmid:21262543
|
Malfitano AM et al. |
Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis. |
2006 |
J. Neuroimmunol. |
pmid:16239036
|
Di Filippo M et al. |
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. |
2008 |
J. Neurol. Neurosurg. Psychiatr. |
pmid:18535023
|
Jean-Gilles L et al. |
Plasma endocannabinoid levels in multiple sclerosis. |
2009 |
J. Neurol. Sci. |
pmid:19695579
|
Contassot E et al. |
Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1. |
2004 |
J. Neuropathol. Exp. Neurol. |
pmid:15453094
|
Ali AB |
Presynaptic Inhibition of GABAA receptor-mediated unitary IPSPs by cannabinoid receptors at synapses between CCK-positive interneurons in rat hippocampus. |
2007 |
J. Neurophysiol. |
pmid:17567776
|
Fischbach T et al. |
Effects of anandamide and noxious heat on intracellular calcium concentration in nociceptive drg neurons of rats. |
2007 |
J. Neurophysiol. |
pmid:17581853
|
Uhelski ML et al. |
Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy. |
2015 |
J. Neurophysiol. |
pmid:25505113
|
Fan P |
Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons. |
1995 |
J. Neurophysiol. |
pmid:7760148
|
Fisyunov A et al. |
Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons. |
2006 |
J. Neurophysiol. |
pmid:16738209
|
De-May CL and Ali AB |
Cell type-specific regulation of inhibition via cannabinoid type 1 receptors in rat neocortex. |
2013 |
J. Neurophysiol. |
pmid:23054605
|
Morisset V and Urban L |
Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord. |
2001 |
J. Neurophysiol. |
pmid:11431486
|
Twitchell W et al. |
Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. |
1997 |
J. Neurophysiol. |
pmid:9242259
|
Ahern GP et al. |
Extracellular cations sensitize and gate capsaicin receptor TRPV1 modulating pain signaling. |
2005 |
J. Neurosci. |
pmid:15917451
|
Tabatadze N et al. |
Sex Differences in Molecular Signaling at Inhibitory Synapses in the Hippocampus. |
2015 |
J. Neurosci. |
pmid:26269634
|
Gómez R et al. |
A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. |
2002 |
J. Neurosci. |
pmid:12417686
|
Gray JM et al. |
Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety. |
2015 |
J. Neurosci. |
pmid:25740517
|
Wang ZJ et al. |
Cannabinoid receptor-mediated regulation of neuronal activity and signaling in glomeruli of the main olfactory bulb. |
2012 |
J. Neurosci. |
pmid:22723687
|
Xiong W et al. |
A common molecular basis for exogenous and endogenous cannabinoid potentiation of glycine receptors. |
2012 |
J. Neurosci. |
pmid:22496565
|
Franklin A et al. |
Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. |
2003 |
J. Neurosci. |
pmid:12944505
|
Shen Y et al. |
A transient receptor potential-like channel mediates synaptic transmission in rod bipolar cells. |
2009 |
J. Neurosci. |
pmid:19439586
|
Derkinderen P et al. |
Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. |
2003 |
J. Neurosci. |
pmid:12657697
|
Clement AB et al. |
Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. |
2003 |
J. Neurosci. |
pmid:12736361
|
Marinelli S et al. |
Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. |
2003 |
J. Neurosci. |
pmid:12716921
|
Massa F et al. |
Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. |
2010 |
J. Neurosci. |
pmid:20445053
|
Tognetto M et al. |
Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. |
2001 |
J. Neurosci. |
pmid:11160380
|
Cadas H et al. |
Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. |
1996 |
J. Neurosci. |
pmid:8656287
|
van der Stelt M et al. |
Exogenous anandamide protects rat brain against acute neuronal injury in vivo. |
2001 |
J. Neurosci. |
pmid:11698588
|
Beltramo M et al. |
Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. |
2000 |
J. Neurosci. |
pmid:10777802
|
Lerner TN et al. |
Endocannabinoid signaling mediates psychomotor activation by adenosine A2A antagonists. |
2010 |
J. Neurosci. |
pmid:20147543
|
Garami A et al. |
Thermoregulatory phenotype of the Trpv1 knockout mouse: thermoeffector dysbalance with hyperkinesis. |
2011 |
J. Neurosci. |
pmid:21289181
|
Justinova Z et al. |
The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys. |
2005 |
J. Neurosci. |
pmid:15944392
|
Subbanna S et al. |
Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic, and memory deficits. |
2013 |
J. Neurosci. |
pmid:23575834
|
Dinis P et al. |
Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. |
2004 |
J. Neurosci. |
pmid:15601931
|
Akerman S et al. |
Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine. |
2013 |
J. Neurosci. |
pmid:24027286
|
Ade KK and Lovinger DM |
Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum. |
2007 |
J. Neurosci. |
pmid:17329438
|
Khlaifia A et al. |
Anandamide, cannabinoid type 1 receptor, and NMDA receptor activation mediate non-Hebbian presynaptically expressed long-term depression at the first central synapse for visceral afferent fibers. |
2013 |
J. Neurosci. |
pmid:23904599
|
Kim D and Thayer SA |
Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture. |
2001 |
J. Neurosci. |
pmid:11319244
|
Khasabova IA et al. |
A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain. |
2008 |
J. Neurosci. |
pmid:18971457
|
Veldhuis WB et al. |
Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases. |
2003 |
J. Neurosci. |
pmid:12764100
|
Cadas H et al. |
Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. |
1997 |
J. Neurosci. |
pmid:9006968
|
Khasabova IA et al. |
Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy. |
2012 |
J. Neurosci. |
pmid:22593077
|
Qin N et al. |
TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. |
2008 |
J. Neurosci. |
pmid:18550765
|
Chemin J et al. |
Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. |
2002 |
J. Neurosci. |
pmid:12177183
|
Gubellini P et al. |
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. |
2002 |
J. Neurosci. |
pmid:12177188
|
Kim SR et al. |
Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro. |
2005 |
J. Neurosci. |
pmid:15659603
|
Thomas EA et al. |
Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. |
1997 |
J. Neurosci. Res. |
pmid:9452020
|
Bari M et al. |
Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells. |
2005 |
J. Neurosci. Res. |
pmid:15920744
|
Molina-Holgado F et al. |
Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. |
2002 |
J. Neurosci. Res. |
pmid:11891798
|
Arias-Carrión O et al. |
Biochemical modulation of the sleep-wake cycle: endogenous sleep-inducing factors. |
2011 |
J. Neurosci. Res. |
pmid:21557294
|
Bajo M et al. |
Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands. |
2009 |
J. Neurosci. Res. |
pmid:18816788
|
Shinjyo N et al. |
Impact of omega-6 polyunsaturated fatty acid supplementation and γ-aminobutyric acid on astrogliogenesis through the endocannabinoid system. |
2013 |
J. Neurosci. Res. |
pmid:23633391
|
Bannerman P et al. |
Early migratory rat neural crest cells express functional gap junctions: evidence that neural crest cell survival requires gap junction function. |
2000 |
J. Neurosci. Res. |
pmid:10972957
|
Mennella I et al. |
Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans. |
2015 |
J. Nutr. |
pmid:26180248
|
Batetta B et al. |
Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. |
2009 |
J. Nutr. |
pmid:19549757
|
Hutchins-Wiese HL et al. |
Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle. |
2012 |
J. Nutr. Biochem. |
pmid:22051448
|
Battista N et al. |
Abnormal anandamide metabolism in celiac disease. |
2012 |
J. Nutr. Biochem. |
pmid:22209002
|
Hutchins HL et al. |
Eicosapentaenoic acid decreases expression of anandamide synthesis enzyme and cannabinoid receptor 2 in osteoblast-like cells. |
2011 |
J. Nutr. Biochem. |
pmid:20951563
|
Gómez R et al. |
Endogenous cannabinoid anandamide impairs cell growth and induces apoptosis in chondrocytes. |
2014 |
J. Orthop. Res. |
pmid:24902823
|
Di Marzo M et al. |
Synthesis, conformational analysis and CB1 binding affinity of hairpin-like anandamide pseudopeptide mimetics. |
2006 |
J. Pept. Sci. |
pmid:16534762
|
Chiba T et al. |
A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells. |
2011 |
J. Pharm. Pharmacol. |
pmid:21492165
|
Hayase T et al. |
Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms. |
2001 |
J. Pharm. Pharmacol. |
pmid:11732755
|
Oz M et al. |
The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. |
2003 |
J. Pharmacol. Exp. Ther. |
pmid:12766252
|
Patel S et al. |
Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. |
2003 |
J. Pharmacol. Exp. Ther. |
pmid:12808005
|
Lichtman AH et al. |
Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15229230
|
Snider NT et al. |
The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18698000
|
Oz M et al. |
The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17682128
|
Ishioka N and Bukoski RD |
A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation. |
1999 |
J. Pharmacol. Exp. Ther. |
pmid:10087011
|
Matias I et al. |
Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:14757851
|
Trezza V and Vanderschuren LJ |
Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats. |
2009 |
J. Pharmacol. Exp. Ther. |
pmid:18948500
|
Lee M et al. |
Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. |
1995 |
J. Pharmacol. Exp. Ther. |
pmid:7473135
|
Fegley D et al. |
Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15579492
|
Brodkin J and Moerschbaecher JM |
SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats. |
1997 |
J. Pharmacol. Exp. Ther. |
pmid:9316868
|